Bluebird Bio or Heron Therapeutics: Which Stock Is the Better Comeback Play?
Biotech stocks can be volatile to the extreme. Former high-flying stocks can crash on a bad clinical outcome, regulatory review, or new competitor on the market. The interesting part, though, is that some former star biotech stocks can, on occasion, regain their momentum. Beaten-down biotech stocks, in short, can be a worthwhile place to unearth outstanding growth stocks.
Which unloved biotech stocks should investors check out? Based on their previous history as potent growth vehicles and overall prospects, Bluebird Bio (NASDAQ: BLUE) and Heron Therapeutics (NASDAQ: HRTX) are two biotechs that appear to have what it takes to rise from the ashes. With that insight, here is a brief overview on each stock's core value proposition.
Image source: Getty Images.
Source Fool.com
